REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 94 filers reported holding REATA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,536,027 | +17.0% | 15,065 | +4.3% | 0.01% | +10.0% |
| Q1 2023 | $1,313,339 | +130.9% | 14,445 | -3.5% | 0.01% | +100.0% |
| Q4 2022 | $568,748 | +45.2% | 14,971 | -4.0% | 0.01% | +66.7% |
| Q3 2022 | $391,802 | -17.3% | 15,591 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $473,810 | -7.2% | 15,591 | 0.0% | 0.00% | +33.3% |
| Q1 2022 | $510,761 | +96.9% | 15,591 | +58.5% | 0.00% | +50.0% |
| Q4 2021 | $259,402 | -73.8% | 9,837 | 0.0% | 0.00% | -77.8% |
| Q3 2021 | $989,701 | -28.9% | 9,837 | 0.0% | 0.01% | -30.8% |
| Q2 2021 | $1,392,231 | +1.5% | 9,837 | +3.5% | 0.01% | -31.6% |
| Q1 2020 | $1,372,240 | -29.4% | 9,507 | 0.0% | 0.02% | -5.0% |
| Q4 2019 | $1,943,516 | +165.4% | 9,507 | +4.2% | 0.02% | +150.0% |
| Q3 2019 | $732,405 | -14.9% | 9,122 | 0.0% | 0.01% | -20.0% |
| Q2 2019 | $860,659 | +20.1% | 9,122 | +8.8% | 0.01% | +25.0% |
| Q1 2019 | $716,324 | +52.4% | 8,381 | 0.0% | 0.01% | +33.3% |
| Q4 2018 | $470,174 | -31.4% | 8,381 | 0.0% | 0.01% | -14.3% |
| Q3 2018 | $685,231 | +153.8% | 8,381 | +8.4% | 0.01% | +133.3% |
| Q2 2018 | $270,000 | +193.5% | 7,732 | +72.7% | 0.00% | +200.0% |
| Q1 2018 | $92,000 | -27.6% | 4,477 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $127,000 | – | 4,477 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 17,000 | $2,930 | 0.01% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 93,711 | $1,612 | 0.00% |
| IFP Advisors, Inc | 300 | $51,708 | 0.00% |